Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 2 días · Sir Charles Spencer Chaplin KBE (16 April 1889 – 25 December 1977) was an English comic actor, filmmaker, and composer who rose to fame in the era of silent film. He became a worldwide icon through his screen persona, the Tramp, and is considered one of the film industry's most important figures.

  2. Hace 1 día · Charles Edward (Leopold Charles Edward George Albert; [note 1] 19 July 1884 – 6 March 1954) was at various points in his life a British prince, a German duke and a Nazi politician. He was the last ruling duke of Saxe-Coburg and Gotha, a state of the German Empire, from 30 July 1900 to 14 November 1918.

  3. en.wikipedia.org › wiki › CharlemagneCharlemagne - Wikipedia

    Hace 1 día · Charlemagne [b] ( / ˈʃɑːrləmeɪn, ˌʃɑːrləˈmeɪn / SHAR-lə-mayn, -⁠MAYN; 2 April 748 [a] – 28 January 814) was King of the Franks from 768, King of the Lombards from 774, and Emperor of what is now known as the Carolingian Empire from 800, holding these titles until his death in 814.

  4. Hace 1 día · Charles V (24 February 1500 – 21 September 1558) was Holy Roman Emperor and Archduke of Austria from 1519 to 1556, King of Spain from 1516 to 1556, and Lord of the Netherlands as titular Duke of Burgundy from 1506 to 1555. He was heir to and then head of the rising House of Habsburg.

  5. Hace 2 días · Charlies Holdings, Inc. (OTCQB: CHUC) is an industry leader in the premium vapor products space, through its subsidiary companies Charlies Chalk Dust, LLC and Don Polly, LLC. Charlie’s Chalk Dust produces high quality vapor products currently distributed in more than 90 countries around the world. Charlie’s Chalk Dust has ...

  6. Hace 5 días · Charlie and Vaggie are disturbed one fateful night by a rattled Husk at their bedroom door carrying a new guest, of sorts, to the hotel: an injured Emily. The newly fallen angel is quickly swept into a dangerous plot that threatens the end of all life in Hell.

  7. Hace 5 días · Charlie’s clinical research focus is ovarian cancer clinical trials. He was UK Lead for the SOLO1 trial, which led to the first-line licence for olaparib in BRCA-mutant ovarian cancer, and for the GOG281/LOGS trial of trametinib, which is the first positive randomised controlled trial in low-grade serous ovarian cancer.